Medicina nuclear
Servizo
![Foto de J.I.](/img/nophoto.png)
J.I.
Arias Pérez
Publicacións nas que colabora con J.I. Arias Pérez (43)
2016
2015
-
Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: Clinical and biological associations during progression from HG1 to HG3
Anticancer Research, Vol. 35, Núm. 1, pp. 569-574
2014
-
Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program
Anticancer Research, Vol. 34, Núm. 1, pp. 269-273
-
CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast
International Journal of Molecular Sciences, Vol. 15, Núm. 11, pp. 19870-19876
-
Positive immunohistochemical expression of bcl-2 in hormone-independent breast carcinomas is associated with a greater lymph node involvement and poor outcome
Medical Oncology, Vol. 31, Núm. 8
2012
-
Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association
Gynecological Endocrinology, Vol. 28, Núm. 4, pp. 278-281
-
CA 15-3 serum levels in patients with ductal breast carcinoma: Relationship with clinicopathological parameters and tumor markers
International Journal of Biological Markers, Vol. 27, Núm. 1, pp. 47-52
-
Infiltrating breast carninomas multifocality: Clinical and biological features
Open Breast Cancer Journal, Vol. 4, pp. 18-23
-
Only in patients with hormone dependent breast infiltrating ductal carcinomas, CA15.3 serum levels are inversely correlated with the immunohistochemical expression of Bcl2
Clinica Chimica Acta, Vol. 413, Núm. 21-23, pp. 1792-1795
2008
-
Reduced clinicopathological influence of hormone-dependence on breast carcinomas in women older than 70 years
International Journal of Biological Markers, Vol. 23, Núm. 1, pp. 58-62
2007
-
CA15.3 sérico y proliferación celular en carcinomas ductales infiltrantes de mama
Revista Espanola de Medicina Nuclear, Vol. 26, Núm. 6, pp. 367-371
2006
-
Concentraciones séricas preoperatorias de antígeno carbohidrato 15.3 y antígeno carcinoembrionario y características clínico-biológicas tisulares de los carcinomas mamarios
Revista Espanola de Medicina Nuclear, Vol. 25, Núm. 3, pp. 180-183
-
Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: A Spanish case-control study
International Journal of Cancer, Vol. 119, Núm. 2, pp. 467-471
-
La expresión del receptor del factor de crecimiento epidérmico (EGFR) en carcinomas mamarios hormonoindependientes
Revista Espanola de Medicina Nuclear, Vol. 25, Núm. 1, pp. 15-19
2005
-
CD44v6 expression in er-negative and PgR-negative infiltrating ductal breast carcinomas [2]
Medicina Clinica, Vol. 125, Núm. 12, pp. 475-476
-
pS2 citosólica y proliferación celular en carcinomas ductales infiltrantes de mama hormonodependientes
Revista Espanola de Medicina Nuclear, Vol. 24, Núm. 3, pp. 185-190
2004
-
Invasión de los ganglios axilares en el carcinoma mamario con receptores hormonales negativos
Medicina Clinica, Vol. 123, Núm. 2, pp. 50-52
-
La expresión de CD44v6, en carcinomas mamarios RE+ y RP+. Resultados preliminares
Oncologia
-
The variant E233G of the rad51d gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations
International Journal of Cancer, Vol. 110, Núm. 6, pp. 845-849
2003
-
Aspectos biológicos peculiares de los carcinomas mucinosos de mama
Revista Espanola de Medicina Nuclear